|Articles|July 27, 2006
Phase Forward Reports second Quarter 2006 Results
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its financial results for the second quarter of 2006.
Advertisement
Waltham, MA – July 27, 2006 – Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its financial results for the second quarter of 2006.
Revenues for the second quarter of 2006 were $24.7 million, a 19% increase from $20.7 million in the second quarter of 2005. Within total revenue, InForm™ license, application hosting and other related revenues were $16.3 million, an increase of 19% from $13.7 million in the prior year period.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5